Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology-Reference-Cited by-同舟云学术

Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology

Published:2021-04 Issue:6 Volume:30 Page:671-684
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Cadarette Suzanne M.¹²³⁴^ORCID,Maclure Malcolm⁵,Delaney J. A. Chris⁶^ORCID,Whitaker Heather J.⁷⁸^ORCID,Hayes Kaleen N.²^ORCID,Wang Shirley V.⁹^ORCID,Tadrous Mina¹¹⁰^ORCID,Gagne Joshua J.⁹^ORCID,Consiglio Giulia P.¹,Hallas Jesper¹¹¹²^ORCID

Affiliation:

1. Leslie Dan Faculty of Pharmacy University of Toronto Toronto Ontario Canada

2. Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

3. Eshelman School of Pharmacy University of North Carolina Chapel Hill North Carolina USA

4. WHO Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector Toronto Ontario Canada

5. Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Vancouver British Columbia Canada

6. College of Pharmacy University of Manitoba Winnipeg Manitoba Canada

7. Department of Mathematic and Statistics The Open University Milton Keynes UK

8. Department of Statistics, Modelling and Economics Public Health England London UK

9. Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

10. Women's College Hospital Toronto Ontario Canada

11. Clinical Pharmacology and Pharmacy IST, University of Southern Denmark Odense Denmark

12. Department of Clinical Pharmacology and Biochemistry Odense University Hospital Odense Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5227

Reference49 articles.

1. Guidelines for good pharmacoepidemiology practice (GPP)

2. A review of uses of health care utilization databases for epidemiologic research on therapeutics

3. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

4. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics

5. The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concomitant Use of Oral Anticoagulants with Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events;Clinical Pharmacology & Therapeutics;2024-09-11

2. Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France;Neurology;2024-09-10

3. Proposing adjustments to heat safety thresholds for junior high and high school sports clubs in Japan;2024-08-18

4. Vacation in Egypt associated with Shiga toxin-producing Escherichia coli infection in children and adolescents, northern Italy, 2023;Eurosurveillance;2024-07-25

5. Thinking Three‐Dimensionally: A Self‐ and Externally‐Controlled Approach to Screening for Drug–Drug–Drug Interactions Among High‐Risk Populations;Clinical Pharmacology & Therapeutics;2024-06-11